Information
-
Trademark
-
90332952
-
Serial Number
90332952
-
Registration Number
7327850
-
International Classifications
-
Filing Date
November 20, 2020
4 years ago
-
Registration Date
March 12, 2024
a year ago
-
Transaction Date
March 12, 2024
a year ago
-
Status Date
March 12, 2024
a year ago
-
Published for Opposition Date
June 15, 2021
3 years ago
-
Location Date
February 02, 2024
a year ago
-
First Use Anywhere Date
November 22, 2023
a year ago
-
First Use In Commerce Date
November 22, 2023
a year ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
YONTEF, DAVID ERIC
-
Attorney Name
Bruce W. Longbottom
Law Office Assigned Location Code
M90
-
Owners
Mark Drawing Code
4000
Mark Identification
AKOUOS
Case File Statements
- GS0051: Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biologics and small molecules both in the nature of pharmaceutical preparations for the treatment of genetically-related inner ear diseases and conditions causing hearing loss; gene therapy products to restore, improve and preserve hearing, namely, genetically engineered tissues for inner ear transplant purposes and drug delivery agents for use in the inner ear consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; gene therapy products, namely, biological preparations for the treatment of inner ear disorders and conditions; viral vectors, non-viral vectors and gene therapy vectors all for medical purposes, namely, therapeutic agents for delivering nucleic acid and other genetic material to nuclei of targeted cells in the human body, for use in gene therapy to treat inner ear disorders and conditions; biotechnological platform technology for gene delivery to biological cells, namely, biological nanoparticles and adenoviruses featuring adeno-associated viral (AAV) vectors therein to provide platforms for specific expressions of biologics with therapeutic effects in gene therapy, all to restore, improve and preserve hearing; biotechnological platform technology for gene delivery to biological cells, namely, biological nanoparticles and adenoviruses featuring adeno-associated viral (AAV) vectors therein to provide platforms for specific expressions of biologics with therapeutic effects in gene therapy, all to treat inner ear disorders and conditions
- TR0010: The wording "Akouos" has no meaning in a foreign language.
Case File Event Statements
-
3/12/2024 - a year ago
46 - NOTICE OF REGISTRATION CONFIRMATION EMAILED
Type: NRCC
-
3/12/2024 - a year ago
45 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
2/3/2024 - a year ago
44 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Type: SUNA
-
2/2/2024 - a year ago
43 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Type: CNPR
-
2/1/2024 - a year ago
42 - STATEMENT OF USE PROCESSING COMPLETE
Type: SUPC
-
1/11/2024 - a year ago
41 - USE AMENDMENT FILED
Type: IUAF
-
2/1/2024 - a year ago
40 - CASE ASSIGNED TO INTENT TO USE PARALEGAL
Type: AITU
-
1/11/2024 - a year ago
39 - TEAS STATEMENT OF USE RECEIVED
Type: EISU
-
9/13/2023 - a year ago
38 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
9/13/2023 - a year ago
37 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
9/13/2023 - a year ago
36 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
9/13/2023 - a year ago
35 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
9/13/2023 - a year ago
34 - TEAS CHANGE OF OWNER ADDRESS RECEIVED
Type: COAR
-
8/4/2023 - a year ago
33 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
8/3/2023 - a year ago
32 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
8/3/2023 - a year ago
31 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
8/3/2023 - a year ago
30 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
8/2/2023 - a year ago
29 - SOU EXTENSION 4 GRANTED
Type: EX4G
-
8/2/2023 - a year ago
28 - SOU EXTENSION 4 FILED
Type: EXT4
-
8/2/2023 - a year ago
27 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
2/9/2023 - 2 years ago
26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
2/7/2023 - 2 years ago
25 - SOU EXTENSION 3 GRANTED
Type: EX3G
-
2/7/2023 - 2 years ago
24 - SOU EXTENSION 3 FILED
Type: EXT3
-
2/7/2023 - 2 years ago
23 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
8/11/2022 - 2 years ago
22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
8/9/2022 - 2 years ago
21 - SOU EXTENSION 2 GRANTED
Type: EX2G
-
8/9/2022 - 2 years ago
20 - SOU EXTENSION 2 FILED
Type: EXT2
-
8/9/2022 - 2 years ago
19 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
2/10/2022 - 3 years ago
18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
2/8/2022 - 3 years ago
17 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
2/8/2022 - 3 years ago
16 - SOU EXTENSION 1 FILED
Type: EXT1
-
2/8/2022 - 3 years ago
15 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
8/10/2021 - 3 years ago
14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
6/15/2021 - 3 years ago
13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
6/15/2021 - 3 years ago
12 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
5/26/2021 - 3 years ago
11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
5/11/2021 - 3 years ago
10 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
5/11/2021 - 3 years ago
9 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
5/11/2021 - 3 years ago
8 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
5/11/2021 - 3 years ago
7 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
5/11/2021 - 3 years ago
6 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
5/11/2021 - 3 years ago
5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Type: AMPX
-
5/7/2021 - 3 years ago
4 - TEAS VOLUNTARY AMENDMENT RECEIVED
Type: PARI
-
5/4/2021 - 3 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
1/26/2021 - 4 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
11/24/2020 - 4 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
